Adagene Announces Authorization of Share Repurchase Program up to US$10 Million
Adagene Announces Authorization of Share Repurchase Program up to US$10 Million GlobeNewswire June 29, 2022 SAN DIEGO and SUZHOU, China, June 29, 2022 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that its board of directors has authorized a...